{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:08Z","timestamp":1793039468193,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10863-025-10072-z","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:52:38Z","timestamp":1757494358000},"page":"437-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of sini decoction-mediated cellular mitochondrial autophagy on M1 macrophage polarization and its impact on a mouse model of peripheral artery disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Zhe","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoqin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"10072_CR1","doi-asserted-by":"publisher","unstructured":"Chen K, Hou C, Xu L, Peng H, He C, Liu J, Wang G, Huang S, Liu X (2022) HSPB1 regulates autophagy and apoptosis in vascular smooth muscle cells in arteriosclerosis obliterans. Cardiovasc Ther 2022(3889419). https:\/\/doi.org\/10.1155\/2022\/3889419","DOI":"10.1155\/2022\/3889419"},{"key":"10072_CR2","doi-asserted-by":"publisher","first-page":"871362","DOI":"10.3389\/fimmu.2022.871362","volume":"13","author":"L Cui","year":"2022","unstructured":"Cui L, Chen L, Dai Y, Ou J, Qiu M, Wang S (2022) Increased level of TIM-3\u2009+\u2009PD-1\u2009+\u2009CD4\u2009+\u2009T cells with altered function might be associated with lower extremity arteriosclerosis obliterans. Front Immunol 13:871362. https:\/\/doi.org\/10.3389\/fimmu.2022.871362","journal-title":"Front Immunol"},{"issue":"9","key":"10072_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097910","volume":"24","author":"E Gusev","year":"2023","unstructured":"Gusev E, Sarapultsev A (2023) Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci 24(9):7910. https:\/\/doi.org\/10.3390\/ijms24097910","journal-title":"Int J Mol Sci"},{"key":"10072_CR4","doi-asserted-by":"publisher","unstructured":"Healthcare Engineering JO (2023) Retracted: virtual reality-assisted percutaneous transluminal angioplasty for interventional treatment of lower-extremity arteriosclerosis obliterans. J Healthc Eng 2023:9843756. https:\/\/doi.org\/10.1155\/2023\/9843756","DOI":"10.1155\/2023\/9843756"},{"issue":"6","key":"10072_CR5","doi-asserted-by":"publisher","first-page":"e2215580","DOI":"10.1001\/jamanetworkopen.2022.15580","volume":"5","author":"CN Hess","year":"2022","unstructured":"Hess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivi\u00e8re A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MP (2022) Rivaroxaban and risk of venous thromboembolism in patients with symptomatic peripheral artery disease after lower extremity revascularization. JAMA Netw Open 5(6):e2215580. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15580","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10072_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1574892817666220119121204","volume":"17","author":"Z Jin","year":"2022","unstructured":"Jin Z, Zhang W, Liu H, Ding A, Lin Y, Wu SX, Lin J (2022) Potential therapeutic application of local anesthetics in cancer treatment. Recent Pat Anticancer Drug Discov 17(4):326\u2013342. https:\/\/doi.org\/10.2174\/1574892817666220119121204","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10072_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T (2022) Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol 12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290","journal-title":"Front Oncol"},{"key":"10072_CR8","doi-asserted-by":"publisher","unstructured":"Liu Y, Cui Y, Zhou Z, Liu B, Liu Z, Li G (2023) Relationship between angiotensin II, vascular endothelial growth factor, and arteriosclerosis obliterans. Dis Markers 2023(1316821). https:\/\/doi.org\/10.1155\/2023\/1316821","DOI":"10.1155\/2023\/1316821"},{"issue":"5","key":"10072_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110309","volume":"38","author":"CS Mantsounga","year":"2022","unstructured":"Mantsounga CS, Lee C, Neverson J, Sharma S, Healy A, Berus JM, Parry C, Ceneri NM, L\u00f3pez-Gir\u00e1ldez F, Chun HJ, Lu Q, Sellke F, Choudhary G, Morrison AR (2022) Macrophage IL-1\u03b2 promotes arteriogenesis by autocrine STAT3- and NF-\u03baB-mediated transcription of pro-angiogenic VEGF-A. Cell Rep 38(5):110309. https:\/\/doi.org\/10.1016\/j.celrep.2022.110309","journal-title":"Cell Rep"},{"issue":"1","key":"10072_CR10","doi-asserted-by":"publisher","first-page":"ftac015","DOI":"10.1093\/femspd\/ftac015","volume":"80","author":"M Mariebernard","year":"2022","unstructured":"Mariebernard M, Mohanty A, Rajendran V (2022) A comprehensive review on classifying fast-acting and slow-acting antimalarial agents based on time of action and target organelle of plasmodium Sp. Pathog Dis 80(1):ftac015. https:\/\/doi.org\/10.1093\/femspd\/ftac015","journal-title":"Pathog Dis"},{"key":"10072_CR11","doi-asserted-by":"publisher","unstructured":"Methods In Medicine CAM, Retracted (2023) Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors. Comput. Math. Methods Med., 2023:9871829.https:\/\/doi.org\/10.1155\/2023\/9871829","DOI":"10.1155\/2023\/9871829"},{"issue":"8","key":"10072_CR12","doi-asserted-by":"publisher","first-page":"e0272079","DOI":"10.1371\/journal.pone.0272079","volume":"17","author":"S Schirm","year":"2022","unstructured":"Schirm S, Haghikia A, Brack M, Ahnert P, Nouailles G, Suttorp N, Loeffler M, Witzenrath M, Scholz M (2022) A biomathematical model of atherosclerosis in mice. PLoS One 17(8):e0272079. https:\/\/doi.org\/10.1371\/journal.pone.0272079. ((PMID: 35921269; PMCID: PMC9348695))","journal-title":"PLoS One"},{"issue":"9","key":"10072_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1308\/rcsann.2021.0335","volume":"104","author":"Z Su","year":"2022","unstructured":"Su Z, Li Y, Yang S, Guo J, Guo L, Gu Y (2022) Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans. Ann R Coll Surg Engl 104(9):667\u2013672. https:\/\/doi.org\/10.1308\/rcsann.2021.0335","journal-title":"Ann R Coll Surg Engl"},{"key":"10072_CR14","doi-asserted-by":"publisher","first-page":"853583","DOI":"10.3389\/fcvm.2022.853583","volume":"9","author":"J Sun","year":"2022","unstructured":"Sun J, Deng Q, Wang J, Duan S, Chen H, Zhou H, Zhou Z, Yu F, Guo F, Liu C, Xu S, Song L, Wang Y, Feng H, Yu L (2022) Novel insight into long-term risk of major adverse cardiovascular and cerebrovascular events following lower extremity arteriosclerosis obliterans. Front Cardiovasc Med 9:853583. https:\/\/doi.org\/10.3389\/fcvm.2022.853583","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10072_CR15","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1532\/hsf.5303","volume":"26","author":"SY Tian","year":"2023","unstructured":"Tian SY (2023) Systemic immune-inflammation index predicts restenosis after interventions for lower extremity arteriosclerosis obliterans. Heart Surg Forum 26(3):E225\u2013E233. https:\/\/doi.org\/10.1532\/hsf.5303","journal-title":"Heart Surg Forum"},{"issue":"3","key":"10072_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s11357-023-00786-6","volume":"45","author":"CE Van Skike","year":"2023","unstructured":"Van Skike CE, DeRosa N, Galvan V, Hussong SA (2023) Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer\u2019s disease. Geroscience 45(3):1987\u20131996. https:\/\/doi.org\/10.1007\/s11357-023-00786-6. (Epub 2023 Apr 13. PMID: 37052770; PMCID: PMC10400743)","journal-title":"Geroscience"},{"issue":"1","key":"10072_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40122-021-00347-9","volume":"11","author":"Y Wu","year":"2022","unstructured":"Wu Y, Tian S, Li C, Zhang W, Xing Q, Chen G (2022) Predictive value of contrast-enhanced ultrasound in chemical lumbar sympathectomy for end-stage arteriosclerosis obliterans of the lower extremities. Pain Ther 11(1):209\u2013223. https:\/\/doi.org\/10.1007\/s40122-021-00347-9","journal-title":"Pain Ther"},{"key":"10072_CR18","doi-asserted-by":"publisher","unstructured":"Xiao D, Song J (2022) Clinical efficacy of interventional therapy on lower extremity arteriosclerosis obliterans and prognostic factors. Comput Math Methods Med, 2022:9190292.\u00a0https:\/\/doi.org\/10.1155\/2022\/9190292","DOI":"10.1155\/2022\/9190292"},{"issue":"3","key":"10072_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.14715\/cmb\/2024.70.3.37","volume":"70","author":"T Xu","year":"2024","unstructured":"Xu T, Zheng C, Wu Y, Chen Z, Miao H (2024) MiR-34a ameliorates arterial blood flow in rats with lower limb arteriosclerosis obliterans via Sirt1 signaling pathway. Cell Mol Biol (Noisy-le-grand) 70(3):248\u2013253. https:\/\/doi.org\/10.14715\/cmb\/2024.70.3.37","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10072_CR20","doi-asserted-by":"publisher","first-page":"1031108","DOI":"10.3389\/fsurg.2022.1031108","volume":"9","author":"B Yang","year":"2023","unstructured":"Yang B, andXiaping Z (2023) The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis. Front Surg 9:1031108. https:\/\/doi.org\/10.3389\/fsurg.2022.1031108","journal-title":"Front Surg"},{"issue":"11","key":"10072_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.5551\/jat.64091","volume":"30","author":"M Yokoi","year":"2023","unstructured":"Yokoi M, Ito T, Kawada Y, Mizoguchi T, Yamamoto J, Mori K, Nakasuka K, Kikuchi S, Fujita H, Kitada S, Goto T, Seo Y (2023) Malondialdehyde-modified low-density lipoprotein as a predictor of major adverse limb events after endovascular therapy in patients with lower extremity arterial disease. J Atheroscler Thromb 30(11):1612\u20131621. https:\/\/doi.org\/10.5551\/jat.64091","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"10072_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s41043-023-00454-7","volume":"42","author":"YY Yuan","year":"2023","unstructured":"Yuan YY, Cao WD, Zhang XH, Du RX, Wang XQ, Li J, Chen J, Yang JZ, Chen JQ (2023) Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans. J Health Popul Nutr 42(1):115. https:\/\/doi.org\/10.1186\/s41043-023-00454-7","journal-title":"J Health Popul Nutr"},{"issue":"21","key":"10072_CR23","doi-asserted-by":"publisher","first-page":"11875","DOI":"10.18632\/aging.205154","volume":"15","author":"M Zhang","year":"2023","unstructured":"Zhang M, Chen Y, Niu F, Luo X, Li J, Hu W (2023a) MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans. Aging 15(21):11875\u201311890. https:\/\/doi.org\/10.18632\/aging.205154","journal-title":"Aging"},{"key":"10072_CR24","doi-asserted-by":"publisher","unstructured":"Zhang T, Li J, Dai J, Yuan F, Yuan G, Chen H, Zhu D, Mao X, Qin L, Liu N, Yang M (2023b) Corrigendum to identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer [Cancer Genetics 276\u2013277, August 2023, Pages 48\u201359]. Cancer Genet 278\u2013279(79). https:\/\/doi.org\/10.1016\/j.cancergen.2023.08.007","DOI":"10.1016\/j.cancergen.2023.08.007"},{"key":"10072_CR25","doi-asserted-by":"publisher","first-page":"ftae003","DOI":"10.1093\/femspd\/ftae003","volume":"82","author":"FY Zhang","year":"2024","unstructured":"Zhang FY, Lian N, Li M (2024) Macrophage pyroptosis induced by Candida albicans. Pathog Dis 82:ftae003. https:\/\/doi.org\/10.1093\/femspd\/ftae003","journal-title":"Pathog Dis"},{"key":"10072_CR26","doi-asserted-by":"publisher","first-page":"105639","DOI":"10.1016\/j.phrs.2021.105639","volume":"169","author":"S Zheng","year":"2021","unstructured":"Zheng S, Huang H, Li Y, Wang Y, Zheng Y, Liang J, Zhang S, Liu M, Fang Z (2021) Yin-xing-tong-mai Decoction attenuates atherosclerosis via activating PPAR\u03b3-LXR\u03b1-ABCA1\/ABCG1 pathway. Pharmacol Res 169:105639 Epub 2021 Apr 28. PMID: 33932607","journal-title":"Pharmacol Res"},{"key":"10072_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2147\/PGPM.S424359","volume":"16","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z (2023) Microarray expression profile and bioinformatic analysis of circular RNA in human arteriosclerosis obliterans. Pharmgenomics Pers Med 16:913\u2013924. https:\/\/doi.org\/10.2147\/PGPM.S424359","journal-title":"Pharmgenomics Pers Med"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-025-10072-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-025-10072-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-025-10072-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:29:32Z","timestamp":1770182972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-025-10072-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10072"],"URL":"https:\/\/doi.org\/10.1007\/s10863-025-10072-z","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Ethics Committee of Shanghai Integrated Traditional Chinese and Western Medicine Hospital and All methods were carried out in accordance with relevant guidelines and regulations. All animal experiments should comply with the ARRIVE guidelines and were conducted in accordance with the UK Animals (Scientific Procedures) Act of 1986 and associated guidelines, the EU Directive 2010\/63\/EU on the protection of animals used for scientific purposes, or the NIH Guide for the Care and Use of Laboratory Animals (NIH Publication No. 8023, revised 1978).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}